1. Home
  2. ELOG vs NXL Comparison

ELOG vs NXL Comparison

Compare ELOG & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

N/A

Current Price

$0.85

Market Cap

11.1M

Sector

Industrials

ML Signal

N/A

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.45

Market Cap

10.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELOG
NXL
Founded
2006
2010
Country
China
United States
Employees
N/A
8
Industry
Integrated Freight & Logistics
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
10.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ELOG
NXL
Price
$0.85
$0.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.5K
223.0K
Earning Date
07-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.52
Revenue Next Year
N/A
$100.00
P/E Ratio
$6.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.31
52 Week High
$3.07
$2.00

Technical Indicators

Market Signals
Indicator
ELOG
NXL
Relative Strength Index (RSI) 41.32 55.12
Support Level N/A $0.35
Resistance Level $0.97 $0.49
Average True Range (ATR) 0.06 0.05
MACD -0.00 0.01
Stochastic Oscillator 0.00 72.11

Price Performance

Historical Comparison
ELOG
NXL

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: